华纳药厂获得重酒石酸去甲肾上腺素注射液药品注册证书

Core Viewpoint - Warner Pharmaceuticals (688799.SH) has received approval from the National Medical Products Administration for the drug registration certificate of heavy tartrate norepinephrine injection, which is intended for use in acute hypotensive states and as an auxiliary treatment for cardiac arrest [1] Group 1 - The heavy tartrate norepinephrine injection is used to restore blood pressure in acute hypotensive states [1] - It can also assist in the treatment of cardiac arrest and maintain blood pressure after resuscitation [1] - The product serves as an auxiliary treatment for shock due to insufficient blood volume, helping to temporarily maintain cerebral and coronary perfusion until volume resuscitation takes effect [1] Group 2 - The heavy tartrate norepinephrine injection has been classified as a Class 3 chemical drug and has passed the consistency evaluation [1]